Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard Rosen

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Brain : a Journal of Neurology|August 12, 2025
Design considerations for C9orf72 disease prevention trialsMichael Benatar, Adam M Staffaroni, Joanne Wuu, et al.
Brain : a Journal of Neurology|October 22, 2021
Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseasesMichael Benatar, Joanne Wuu, Caroline McHutchison, et al.
Nature Reviews. Neurology|May 29, 2024
Publisher Correction: The Miami Framework for ALS and related neurodegenerative disorders: an integrated view of phenotype and biologyMichael Benatar, Joanne Wuu, Edward D Huey, et al.
Headache|August 16, 2024
The headache research priorities: Research goals from the American Headache Society and an international multistakeholder expert groupTodd J Schwedt, Amynah A Pradhan, Michael L Oshinsky, et al.
Nature Reviews. Neurology|May 20, 2024
The Miami Framework for ALS and related neurodegenerative disorders: an integrated view of phenotype and biologyMichael Benatar, Joanne Wuu, Edward D Huey, et al.
JAMA Neurology|February 27, 2023
Prevalence, Timing, and Network Localization of Emergent Visual Creativity in Frontotemporal DementiaAdit Friedberg, Lorenzo Pasquini, Ryan Diggs, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 1, 2019
New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measuresAdam L Boxer, Michael Gold, Howard Feldman, et al.
Neurology|May 7, 2020
Revised Self-Monitoring Scale: A potential endpoint for frontotemporal dementia clinical trialsGianina Toller, Kamalini Ranasinghe, Yann Cobigo, et al.
The Lancet. Neurology|August 21, 2021
Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance studyElisabeth H Thijssen, Renaud La Joie, Amelia Strom, et al.
Nature Methods|June 10, 2022
ASLPrep: a platform for processing of arterial spin labeled MRI and quantification of regional brain perfusionAzeez Adebimpe, Maxwell Bertolero, Sudipto Dolui, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Brain : a Journal of Neurology|August 12, 2025
Design considerations for C9orf72 disease prevention trialsMichael Benatar, Adam M Staffaroni, Joanne Wuu, et al.
Brain : a Journal of Neurology|October 22, 2021
Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseasesMichael Benatar, Joanne Wuu, Caroline McHutchison, et al.
Nature Reviews. Neurology|May 29, 2024
Publisher Correction: The Miami Framework for ALS and related neurodegenerative disorders: an integrated view of phenotype and biologyMichael Benatar, Joanne Wuu, Edward D Huey, et al.
Headache|August 16, 2024
The headache research priorities: Research goals from the American Headache Society and an international multistakeholder expert groupTodd J Schwedt, Amynah A Pradhan, Michael L Oshinsky, et al.
Nature Reviews. Neurology|May 20, 2024
The Miami Framework for ALS and related neurodegenerative disorders: an integrated view of phenotype and biologyMichael Benatar, Joanne Wuu, Edward D Huey, et al.
JAMA Neurology|February 27, 2023
Prevalence, Timing, and Network Localization of Emergent Visual Creativity in Frontotemporal DementiaAdit Friedberg, Lorenzo Pasquini, Ryan Diggs, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 1, 2019
New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measuresAdam L Boxer, Michael Gold, Howard Feldman, et al.
Neurology|May 7, 2020
Revised Self-Monitoring Scale: A potential endpoint for frontotemporal dementia clinical trialsGianina Toller, Kamalini Ranasinghe, Yann Cobigo, et al.
The Lancet. Neurology|August 21, 2021
Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance studyElisabeth H Thijssen, Renaud La Joie, Amelia Strom, et al.
Nature Methods|June 10, 2022
ASLPrep: a platform for processing of arterial spin labeled MRI and quantification of regional brain perfusionAzeez Adebimpe, Maxwell Bertolero, Sudipto Dolui, et al.
Pageof 7